(2003)

88 Op. Att'y Gen. 120
Maryland Attorney General Reports·Decided August 29, 2003·Published

Opinion

Dear Robert R. Bass, M.D., Executive Director Maryland Institute for Emergency

A recent federal initiative has encouraged public safety personnel, such as law enforcement officers, firefighters, and emergency medical services personnel, to undergo voluntary smallpox vaccination as a precaution against contracting that disease when responding to a bioterrorist incident. As part of that initiative, Congress addressed compensation of individuals who may suffer adverse effects from smallpox vaccination in two pieces of legislation. One law, which was enacted as part of the Homeland Security Act of 2002, is designed to protect those who carry out the smallpox vaccination program, by shifting tort liability to the federal government and limiting that liability to fault-based claims under the Federal Tort Claims Act. The other law, known as the Smallpox Emergency Personnel Protection Act of 2003 ("SEPPA"), creates a new no-fault federal remedy for those who are voluntarily vaccinated as part of the federal initiative or are infected by contact with a person who received such a vaccination.

You have asked for our opinion on the availability of compensation for a Maryland public safety worker who has an adverse reaction to his or her own vaccination or to the vaccination of a co-worker. Your request requires an assessment of the recent federal legislation and of the Maryland Workers' Compensation Act.

For the reasons set forth in this opinion, we conclude:

(1) Public safety personnel who are voluntarily vaccinated as part of the federal initiative and who suffer adverse reactions to their vaccinations will be eligible for benefits under SEPPA, provided they meet the other requirements of that statute. Benefits received under SEPPA are not based on fault, but will be reduced by the amount of any benefits received under the Maryland Workers' Compensation Act. To the extent that these personnel also have claims against entities involved in the manufacture, distribution, or administration of the vaccine, they will be limited to asserting fault-based claims against the federal government under the Homeland Security Act of 2002, and any benefits will be offset by any compensation received under SEPPA.

(2) The two federal statutes also specifically provide for compensation of an individual who is infected and suffers an injury from contact with another individual vaccinated under the federal initiative. Thus, a Maryland public safety worker who is injured as a result of the vaccination of a co-worker will be eligible for compensation under federal law. Again, benefits under federal law will be offset to the extent the individual receives compensation under the State workers' compensation law.

(3) It is likely that the Workers' Compensation Commission or a reviewing court would hold that adverse reactions or complications experienced by a public safety worker arising from voluntary vaccination of the public safety worker or of a public safety coworker vaccinated as part of the federal program would qualify as an accidental injury or as an occupational disease under the Maryland Workers' Compensation Act.

I
Background
A. Smallpox

According to the Centers for Disease Control and Prevention ("CDC"), smallpox is caused by the variola virus that emerged in human populations thousands of years ago. The most common form is known as "variola major," which results in an extensive rash and high fever. That form of the disease has an overall fatality rate of about 30 per cent, although some subtypes of the virus are more lethal. See CDC Smallpox Fact Sheet — Smallpox Overview (December 9, 2002).1

A successful worldwide vaccination program has resulted in eradication of the disease. According to the CDC, the last case of smallpox in the United States was in 1949 and the last naturally occurring case in the world was in Somalia in 1977. Routine vaccination of the general public against smallpox was halted in the United States as unnecessary. However, there is now concern that the variola virus might be used as an agent of bioterrorism. Accordingly, the federal and state governments are taking precautions to deal with a smallpox outbreak, including vaccination of key personnel.

B. Smallpox Vaccination Program

On December 13, 2002, the President of the United States announced that, in light of the threat of bioterrorism, smallpox vaccine would be made available on a voluntary basis to medical professionals and emergency personnel and response teams that would be the first on the scene in a smallpox emergency.2 To implement that decision, the Secretary of Health and Human Services issued a declaration on January 24, 2003, pursuant to the recently enacted Homeland Security Act of 2002, that certain "countermeasures" should be taken for the prevention or treatment of smallpox, including voluntary smallpox vaccination. The declaration targets certain categories of individuals for the program, including "[p]ublic safety personnel, including, but not limited to, law enforcement officers, firefighters, security, and emergency medical personnel who may be called upon to assist smallpox response teams. . . ."68 Fed. Reg. 4212 (January 28, 2003).3

The smallpox vaccine currently available is a live-virus vaccine made from a virus related to smallpox. A small number of those individuals who are vaccinated against smallpox will experience adverse reactions, which can be serious or life threatening. In addition, the vaccine virus may spread to an individual who has not been vaccinated from an individual who has been vaccinated. CDC Smallpox Fact Sheet — Vaccine Overview (March 31, 2003).4

II
Federal Liability and Compensation Legislation
The compensation provisions of SEPPA and the Homeland Security Act of 20025 were triggered by the January 2003 declaration of the Secretary of Health and Human Services. Together, they provide a basis for federal compensation of public safety personnel in Maryland, although the benefits provided under these laws may be adjusted if it is determined that the State workers' compensation law also provides benefits.

A. The Smallpox Emergency Personnel Protection Act of 2003

The Smallpox Emergency Personnel Protection Act of 2003 ("SEPPA"), Pub.L. 108-20, 117 Stat. 638, codified at 42 U.S.C. § 239 et seq., was signed by the President on April 30, 2003, and was made effective retroactively to November 25, 2002. SEPPA is designed to provide no-fault compensation for injuries arising from an adverse reaction to an individual's own vaccination or to the vaccination of a co-worker as part of the federal initiative. Specifically, it provides certain types of compensation to an "eligible individual" for a "covered injury."

To qualify for SEPPA coverage, a public safety worker must be a participant in a smallpox emergency response plan approved by the Secretary of Health and Human Services and must undergo vaccination as part of that plan. In particular, a public safety worker who suffers injury as a result of a smallpox vaccination must fit the statutory definition of "eligible individual," which includes an individual:

Free access — add to your briefcase to read the full text and ask questions with AI

(2003), 88 Op. Att'y Gen. 120 (Md. 2003).

88 Op. Att'y Gen. 120 ((2003)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Laird v. Nelms
406 U.S. 797 (Supreme Court, 1972)
Rose v. Arkansas State Police
479 U.S. 1 (Supreme Court, 1986)
Natalia Makarova v. United States
201 F.3d 110 (Second Circuit, 2000)
Harris v. Board of Education
825 A.2d 365 (Court of Appeals of Maryland, 2003)
Monette v. Manatee Memorial Hosp.
579 So. 2d 195 (District Court of Appeal of Florida, 1991)
Montgomery County v. Wade
690 A.2d 990 (Court of Appeals of Maryland, 1997)
Means v. Baltimore County
689 A.2d 1238 (Court of Appeals of Maryland, 1997)
Livering v. Richardson's Restaurant
823 A.2d 687 (Court of Appeals of Maryland, 2003)
Smith v. Seamless Rubber Co.
150 A. 110 (Supreme Court of Connecticut, 1930)
Hines v. Baechtel
113 A. 126 (Court of Appeals of Maryland, 1921)
Saintsing v. Steinbach Co.
66 A.2d 158 (Supreme Court of New Jersey, 1949)
Saintsing v. Steinbach Company
64 A.2d 99 (New Jersey Superior Court App Division, 1949)
Guillory v. St. Jude Medical Center
675 So. 2d 1198 (Louisiana Court of Appeal, 1996)